The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Ezetimibe and ezetimibe/simvastatin

Australian Public Assessment Report

AusPAR

AusPAR: Ezetrol/Vytorin [PDF, 1.37 MB]

AusPAR: Ezetrol/Vytorin [Word, 1.25 MB]

Attachment: Product Information: Ezetrol [PDF, 336.54 KB]

Attachment: Product Information: Ezetrol [Word, 379 KB]

Attachment: Product Information: Vytorin [PDF, 596.42 KB]

Attachment: Product Information: Vytorin [Word, 548.5 KB]

Attachment: Extract from Clinical Evaluation Report: Ezetrol/Vytorin [PDF, 3.03 MB]

Attachment: Extract from Clinical Evaluation Report: Ezetrol/Vytorin [Word, 5.26 MB]

Device/Product Name

Ezetrol / Vytorin

Active ingredients

Ezetimibe and ezetimibe / simvastatin

AusPAR Date

26 June 2017

Published

16 August 2017

Submission Number

PM-2015-01525-1-3

Submission Type

Extension of indications

Decision

Approved